NEW YORK – Ares Genetics, a Curetis Group company, will collaborate with BGI Group to make molecular tests for coronavirus 2019-nCoV available in Europe.
Ares will launch a next-generation sequencing testing service for the virus using BGI reagents. The firm will also collaborate, along with Curetis and BGI, in the distribution of NGS and PCR testing kits.